The twelve-month consensus analyst price target for Organigram Global Inc. (NASDAQ and TSX: OGI) fluctuates based on recent equity research updates, hovering on average around $3.26 USD (or equivalent regional currency metrics depending on the exchange). Financial analysts covering the cannabis producer issue ratings ranging from moderate buy to strong buy recommendations, pointing to anticipated revenue growth, international market expansions, cost reduction initiatives, and margin improvements as key catalysts that could drive the stock price higher from its current trading levels over the coming year.